0I5P.L

CymaBay Therapeutics, Inc. [0I5P.L] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

0I5P.L Stock Summary

In the News

0I5P.L Financial details

Company Rating
Neutral
Market Cap
3.73B
Income
-105.37M
Revenue
31.07M
Book val./share
2.58
Cash/share
3.48
Dividend
-
Dividend %
-
Employees
101
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-26.89
Forward P/E
-34.19
PEG
14.65
P/S
53.08
P/B
7.43
P/C
9.33
P/FCF
-42.4
Quick Ratio
22.31
Current Ratio
22.76
Debt / Equity
0.37
LT Debt / Equity
0.34
-
-
EPS (TTM)
-0.99
EPS next Y
-0.95
EPS next Q
-0.4
EPS this Y
-18.18%
EPS next Y
-4.27%
EPS next 5Y
-382.71%
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
15.63%
-
-
-
-
SMA20
12.48%
SMA50
39.47%
SMA100
135.58%
Inst Own
-
Inst Trans
-
ROA
-20%
ROE
-63%
ROC
-0.19%
Gross Margin
-33%
Oper. Margin
-161%
Profit Margin
-176%
Payout
-
Shs Outstand
66.44M
Shs Float
96.64M
-
-
-
-
Target Price
-
52W Range
0.0-32.45
52W High
-
52W Low
-
RSI
82.44
Rel Volume
0.96
Avg Volume
2.72K
Volume
2.61K
Perf Week
0.12%
Perf Month
35.45%
Perf Quarter
-
Perf Half Y
109.28%
-
-
-
-
Beta
0.32
-
-
Volatility
0.01%, 3.2%
Prev Close
0%
Price
32.48
Change
0%

0I5P.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000.29
Net income per share
-1.53-0.74-1.27-1.21-0.99
Operating cash flow per share
-1.46-0.65-0.98-0.96-0.68
Free cash flow per share
-1.47-0.65-0.98-0.96-0.69
Cash per share
2.852.122.631.543.71
Book value per share
2.782.071.870.412.75
Tangible book value per share
2.782.071.870.412.75
Share holders equity per share
2.782.071.870.412.75
Interest debt per share
0.010.010.751.21.21
Market cap
406.89M400.27M227.38M546.14M2.53B
Enterprise value
384.17M373.82M153.15M616.77M2.44B
P/E ratio
-3.96-7.85-2.53-5.15-24.02
Price to sales ratio
000081.45
POCF ratio
-4.16-8.95-3.27-6.5-34.89
PFCF ratio
-4.14-8.95-3.27-6.48-34.68
P/B Ratio
2.182.81.7115.118.66
PTB ratio
2.182.81.7115.118.66
EV to sales
000078.49
Enterprise value over EBITDA
-3.76-7.1-1.76-6.67-24.15
EV to operating cash flow
-3.92-8.36-2.21-7.34-33.62
EV to free cash flow
-3.91-8.35-2.2-7.32-33.42
Earnings yield
-0.25-0.13-0.4-0.19-0.04
Free cash flow yield
-0.24-0.11-0.31-0.15-0.03
Debt to equity
000.382.510.37
Debt to assets
000.250.640.25
Net debt to EBITDA
0.220.50.85-0.760.91
Current ratio
11.5115.3810.418.9410.96
Interest coverage
00-33.91-6.25-5.37
Income quality
0.950.880.770.790.69
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00002.58
Intangibles to total assets
00000
Capex to operating cash flow
00000.01
Capex to revenue
0000-0.01
Capex to depreciation
-0.39-0.03-0.13-0.21-0.65
Stock based compensation to revenue
00000
Graham number
9.795.877.33.347.84
ROIC
-0.55-0.37-0.47-0.73-0.25
Return on tangible assets
-0.5-0.33-0.44-0.75-0.24
Graham Net
2.571.971.650.342.37
Working capital
185.29M141.73M172.73M122.63M366.96M
Tangible asset value
186.35M142.71M132.94M36.15M292.26M
Net current asset value
183.54M140.47M121.72M32.38M261.37M
Invested capital
000.382.510.37
Average receivables
343.5K482K138.5K00
Average payables
2.24M1.37M1.48M1.91M2.46M
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
1.14K133.411.45K563.442.05K
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
0.322.740.250.650.18
Inventory turnover
00000
ROE
-0.55-0.36-0.68-2.93-0.36
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.2300.300
Net income per share
-0.3-0.29-0.01-0.32-0.37
Operating cash flow per share
-0.210.07-0.25-0.25-0.24
Free cash flow per share
-0.210.06-0.25-0.25-0.24
Cash per share
1.542.412.094.153.48
Book value per share
0.411.061.063.092.58
Tangible book value per share
0.411.061.063.092.58
Share holders equity per share
0.411.061.063.092.58
Interest debt per share
1.081.021.021.031.01
Market cap
546.15M834.71M1.13B1.6B2.7B
Enterprise value
616.78M870.73M1.2B1.43B2.61B
P/E ratio
-5.13-7.25-350.51-11.83-16.11
Price to sales ratio
26.96036.52047.38K
POCF ratio
-29.12129.8-44.54-61.34-98.63
PFCF ratio
-29.1133.85-44.41-61.34-97.99
P/B Ratio
15.118.0110.454.929.24
PTB ratio
15.118.0110.454.929.24
EV to sales
30.44038.59045.76K
Enterprise value over EBITDA
-26.48-32.6410.69K-44.83-61.46
EV to operating cash flow
-32.88135.4-47.06-54.86-95.27
EV to free cash flow
-32.86139.63-46.93-54.86-94.65
Earnings yield
-0.05-0.030-0.02-0.02
Free cash flow yield
-0.030.01-0.02-0.02-0.01
Debt to equity
2.510.910.920.320.37
Debt to assets
0.640.390.440.230.25
Net debt to EBITDA
-3.03-1.35572.685.32.17
Current ratio
8.945.2212.5222.7610.96
Interest coverage
-5.76-6.1-0.02-6.65-8.36
Income quality
0.7-0.2231.480.770.65
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.3600.3700
Research and developement to revenue
0.7900.620398.12
Intangibles to total assets
00000
Capex to operating cash flow
0-0.03000.01
Capex to revenue
0000-3.16
Capex to depreciation
-0.07-0.98-0.330-3.21
Stock based compensation to revenue
0.1200.1100
Graham number
1.682.650.434.724.63
ROIC
-0.18-0.130-0.07-0.1
Return on tangible assets
-0.19-0.120-0.08-0.1
Graham Net
0.340.970.942.972.22
Working capital
122.63M196.22M206.18M427.99M366.96M
Tangible asset value
36.15M104.19M108.41M326.19M292.26M
Net current asset value
32.38M101.59M105.83M322.8M261.37M
Invested capital
2.510.910.920.320.37
Average receivables
00000
Average payables
787.5K1.36M3.11M3.66M3.28M
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
533.19738.541.96K1.14K6.15K
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
0.170.120.050.080.01
Inventory turnover
00000
ROE
-0.74-0.28-0.01-0.1-0.14
Capex per share
00000

0I5P.L Frequently Asked Questions

What is CymaBay Therapeutics, Inc. stock symbol ?

CymaBay Therapeutics, Inc. is a US stock , located in Newark of Ca and trading under the symbol 0I5P.L

What is CymaBay Therapeutics, Inc. stock quote today ?

CymaBay Therapeutics, Inc. stock price is $32.48 today.

Is CymaBay Therapeutics, Inc. stock public?

Yes, CymaBay Therapeutics, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Same Price Range
Similar Market Cap